News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588,130 Results
Type
Article (42394)
Company Profile (348)
Press Release (545388)
Section
Business (167253)
Career Advice (2432)
Deals (30253)
Drug Delivery (102)
Drug Development (78525)
Employer Resources (149)
FDA (14335)
Job Trends (12967)
News (295326)
Policy (28456)
Tag
Academia (2652)
Alliances (42704)
Alzheimer's disease (1319)
Approvals (14285)
Artificial intelligence (148)
Bankruptcy (316)
Best Places to Work (10649)
Biotechnology (278)
Breast cancer (187)
Cancer (1380)
Cardiovascular disease (119)
Career advice (2043)
Cell therapy (295)
Clinical research (62562)
Collaboration (477)
Compensation (196)
COVID-19 (2520)
C-suite (120)
Data (1390)
Diabetes (173)
Diagnostics (5639)
Earnings (60252)
Employer resources (137)
Events (87786)
Executive appointments (403)
FDA (15000)
Funding (434)
Gene therapy (212)
GLP-1 (632)
Government (4180)
Healthcare (17182)
Infectious disease (2612)
Inflammatory bowel disease (121)
Interviews (520)
IPO (14100)
Job creations (2735)
Job search strategy (1679)
Layoffs (408)
Legal (6001)
Lung cancer (209)
Manufacturing (193)
Medical device (10991)
Medtech (10995)
Mergers & acquisitions (16309)
Metabolic disorders (476)
Neuroscience (1665)
NextGen Class of 2024 (5960)
Non-profit (4108)
Northern California (1587)
Obesity (265)
Opinion (210)
Parkinson's disease (103)
Patents (120)
People (53192)
Phase I (19614)
Phase II (27642)
Phase III (20587)
Pipeline (511)
Postmarket research (2388)
Preclinical (8301)
Radiopharmaceuticals (246)
Rare diseases (279)
Real estate (4466)
Regulatory (19719)
Research institute (2263)
Resumes & cover letters (360)
Southern California (1419)
Startups (3155)
United States (14079)
Vaccines (540)
Weight loss (198)
Date
Today (120)
Last 7 days (558)
Last 30 days (2282)
Last 365 days (33584)
2024 (33439)
2023 (37471)
2022 (48408)
2021 (52018)
2020 (49980)
2019 (42541)
2018 (32084)
2017 (29605)
2016 (28150)
2015 (32900)
2014 (25341)
2013 (20525)
2012 (21738)
2011 (22667)
2010 (20372)
Location
Africa (737)
Arizona (138)
Asia (35805)
Australia (7122)
California (3626)
Canada (1383)
China (289)
Colorado (159)
Connecticut (158)
Europe (80201)
Florida (493)
Georgia (119)
Illinois (346)
Indiana (201)
Maryland (607)
Massachusetts (2720)
Michigan (167)
Minnesota (251)
New Jersey (1044)
New York (1032)
North Carolina (706)
Northern California (1587)
Ohio (129)
Pennsylvania (818)
South America (1015)
Southern California (1419)
Texas (503)
Utah (106)
Washington State (373)
588,130 Results for "tarveda therapeutics fomerly known as blend therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Pharm Country
Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner
Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma.
May 22, 2024
·
2 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Business
Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Targeting Neurological Diseases
Ascidian Therapeutics today announced a research collaboration and licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.
June 18, 2024
·
3 min read
Editorial
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout Rare Disease Deal
Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead Pharmaceuticals on RNAi-based medicines.
December 4, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Asthma Therapeutics Market Size to Reach USD 22.0 Billion by 2032, Impelled by Favorable Government Initiatives
Asthma Therapeutics Market Outlook 2024-2032:
August 8, 2024
·
10 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Press Releases
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
1 of 58,813
Next
